Pfizer Inc. Developing 15 New Drugs That Could Be Approved For Sale By 2020
Pharmaceutical company Pfizer Inc. (NYSE:$PFE) saw its revenue increase in its latest quarter as the drug manufacturer says it forecasts more product launches in the next several years combined with fewer drug-exclusivity losses.
…
California Judge Throws Out $417M Cancer Verdict Against Johnson & Johnson
Have you heard the latest in the drug manufacturers industry? A California judge on Friday, October 20, threw out a $417 million verdict against pharmaceutical company Johnson & Johnson (NYSE:$JNJ) in a lawsuit by a …
Bayer Funds $100 Million for Agri-Biotech Startup
Bayer AG (NASDAQ:$BAYRY) is one of the world’s largest agricultural chemical companies. Recently, the company joined a $100 bet that the next breakthrough in crop fertilizers will be found inside a biological Petri dish.
… Read
Glaukos Corp Lowers Revenue Expectation, 16-Quarter Streak Coming to an End?
Glaukos Corp. (NASDAQ:$GKOS) is a medical device manufacturer with an eye on glaucoma. The company’s shares are plundering 16.7% today, after management made some adjustments to this year’s total revenue expectations.
The company’s …
Teva Pharmaceutical Shares Surged Today, Here’s Why
On Monday, September 11, after Teva Pharmaceutical announced that it had officially filled its open CEO seat, shares of the pharmaceutical company increased 18%.
What Happened?
The Israel-based company disclosed today that it …
Adamas Pharmaceuticals’ Stock Skyrockets After its Drug Gocovri Gain FDA Approval
Drug manufacturer and research company Adamas Pharmaceuticals (NASDAQ:$ADMS) saw its shares rise on Friday, August 25th. The rise can largely be attributed to the fact that the U.S. Food and Drug Administration (FDA) granted approval …
Johnson & Johnson to Pay $417 Million in Damages After Lawsuit Claims the Company Did Not Properly Address Cancer Risks of its Products
On Monday, August 21st, pharmaceutical giant Johnson & Johnson (NYSE:$JNJ) lost a lawsuit and was ordered to pay a total of $417 million in damages to Eva Echeverria. $70 million was to be paid in …
Mylan NV Just Wrapped Up the $465 Million EpiPen Settlement
The public has now been made aware that Mylan NV (NASDAQ:$MYL) has finalized a $465 million deal with the United States Department of Justice. This is significant news as it marks the end of a …
Horizon Pharma Increased More Than 13% Today, Here’s Why
On August 17, shares of Horizon Pharma (NASDAQ:$HZNP) increased more than 13%. It all started after the law firm of Green, Griffith & Borg-Breen asserted one of the company’s patents covering Pennsaid 2% against a …
Teva Pharmaceutical Looking for Partners
Are you interested in the drug manufacturers industry? If so, here’s some news! Israel’s Teva Pharmaceutical Industries (TLV:$TEVA) is now looking to enter into partnership with other drug-makers in an attempt to fund some of …